Literature DB >> 2535497

Purification and immunochemical characterization of ascitic fluid glycoproteins containing certain tumor-associated and blood group antigen markers.

M Venegas1, L Liu, L Lovell, L E Davis, B Anderson, T Wilbanks, M Hass, G Manderino, H Rittenhouse.   

Abstract

Ascitic fluids from patients with various types of cancer were screened for the CA 19-9 and CA 125 tumor-associated antigenic activities. Two fluids exhibiting the highest activities were tested for their binding to various lectin-Sepharose columns resulting in both being bound best to wheat germ agglutinin (WGA) Sepharose. The WGA column eluate of one fluid was further chromatographed by HPLC and three peaks were obtained with approximate molecular weights of 3.65 MDa, 664 kDa and 330 kDa, of which only the largest fraction contained the CA 19-9 activity. The fluids were also fractionated on a Sephacryl S-400 column with most of the activity being present in or near the void volume. Monoclonal antibodies were used to demonstrate that the purified glycoproteins also contained the blood group A determinant, the four Lewis determinants Le(a), Le(b), Le(x) and Le(y), and the sialylated-Le(x) determinant, while other antibody analyses failed to detect other blood group and/or carbohydrate sequence determinants. Some of the blood group expressions could be separated from the CA 19-9 and CA 125 active glycoproteins by adsorption with various lectins other than the WGA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535497     DOI: 10.1007/bf01053774

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  45 in total

1.  A simple ultraviolet spectrophotometric method for the determination of protein.

Authors:  W J WADDELL
Journal:  J Lab Clin Med       Date:  1956-08

2.  Unexpected occurrence of the Ca 19-9 tumor marker in normal human seminal plasma.

Authors:  G Uhlenbruck; U van Meensel-Maene; F G Hanisch; C Dienst
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1984-06

3.  Elevation of CA 125 in patients with benign and malignant ascites.

Authors:  J F Bergmann; J M Bidart; M George; M Beaugrand; V G Levy; C Bohuon
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

4.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

5.  Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.

Authors:  L D Papsidero; T Nemoto; G A Croghan; T M Chu
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma.

Authors:  M Herlyn; H F Sears; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

7.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

Review 8.  Carbohydrate sequences detected by murine monoclonal antibodies.

Authors:  J L Magnani
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

Review 9.  Tumor-associated glycolipid antigens, their metabolism and organization.

Authors:  S Hakomori
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

10.  Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.

Authors:  R C Bast; T L Klug; E Schaetzl; P Lavin; J M Niloff; T F Greber; V R Zurawski; R C Knapp
Journal:  Am J Obstet Gynecol       Date:  1984-07-01       Impact factor: 8.661

View more
  2 in total

1.  An improved ELISA for the determination of sialyl Lewis(x) structures on purified glycoconjugates.

Authors:  I Katnik; M T Goodarzi; G A Turner
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

2.  Binding of type 1-piliated Escherichia coli to vaginal mucus.

Authors:  M F Venegas; E L Navas; R A Gaffney; J L Duncan; B E Anderson; A J Schaeffer
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.